Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.60NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.7.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.2 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.2 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.10 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.10 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.102 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.102 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.213NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.213NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.56 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.56 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.91.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.4.14 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.14 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.359NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.359NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.2 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.2 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
M.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
M.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.82 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.82 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.466.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.466.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.8 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used